Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Coastal Meds, LLC. is recalling 1,506 vials of Hydroxocobalamin Injectable due to the presence of unknown particulate matter. The product was distributed nationwide.
Bayer is recalling specific Alka-Seltzer Plus packages because the ingredients listed on the front sticker may not match the actual product inside the carton.
Coastal Meds, LLC. is recalling 635 vials of Pyridoxine Injectable due to the presence of unknown particulate matter.
Coastal Meds, LLC. is recalling 3,733 vials of LIPO-DEN EXTREME Injectable-30 mL due to the presence of unknown particulate matter.
Premier Pharmacy Labs is recalling specific lots of Morphine Sulfate Injection because routine testing of other lots detected microbial contamination risks.
Premier Pharmacy Labs is recalling NeoStigmine Methylsulfate syringes because routine testing of other lots detected microbial contamination risks.
Coastal Meds, LLC. is recalling LIPO-B Injectable-30 mL vials due to the presence of unknown particulate matter.
Coastal Meds, LLC. is recalling 745 vials of Cyanocobalamin Injectable due to the presence of unknown particulate matter.
Coastal Meds, LLC. is recalling 1,309 vials of LIPO-DEN Injectable-30 mL because of the presence of unknown particulate matter.
Lyne Laboratories is recalling 23,453 units of Fluocinolone Acetonide Topical Oil because the product is subpotent. The recall is voluntary and classified as FDA Class II.
Coastal Meds, LLC. is recalling 4,524 vials of Methylcobalamin Injectable due to the presence of unknown particulate matter.
Time-Cap Laboratories is recalling specific lots of Ibuprofen Tablets USP 600 mg due to odor complaints linked to CGMP deficiencies.
Time-Cap Laboratories is recalling specific lots of Ibuprofen Caplets 200 mg due to odor complaints and CGMP deficiencies. The recall covers nationwide distribution.
Time-Cap Laboratories is recalling specific lots of Ibuprofen Tablets USP 400 mg due to odor complaints related to CGMP deficiencies.
McKesson Packaging Services is recalling Diltiazem HCl Extended-Release Capsules, 240 mg, because stability testing showed high dissolution results.
Time-Cap Laboratories is recalling specific lots of Ibuprofen 600 mg tablets due to odor complaints linked to CGMP deficiencies.
Lyne Laboratories is recalling 17,939 units of Fluocinolone Acetonide Topical Oil ear drops because the medication is subpotent.
Time-Cap Laboratories is recalling various strengths of ibuprofen tablets due to odor complaints related to CGMP deficiencies.
Time-Cap Laboratories is recalling specific lots of Ibuprofen Tablets USP 400 mg due to odor complaints related to Current Good Manufacturing Practice (CGMP) deficiencies.
Time-Cap Laboratories is recalling specific lots of Ibuprofen Tablets USP 600 mg due to odor complaints linked to CGMP deficiencies.
Time-Cap Laboratories is recalling specific bottles of Ibuprofen 200 mg caplets due to odor complaints linked to CGMP deficiencies.
Time-Cap Laboratories is recalling specific lots of 800 mg ibuprofen tablets due to odor complaints linked to CGMP deficiencies.
Time-Cap Laboratories is recalling specific lots of Ibuprofen 800 mg tablets due to odor complaints linked to CGMP deficiencies.
McKesson Packaging Services is recalling Diltiazem CD 180 mg capsules because stability testing showed high dissolution results.
Time-Cap Laboratories is recalling specific lots of ibuprofen tablets due to odor complaints linked to CGMP deficiencies.